Verve Therapeutics is a biotechnology company focused on discovering and developing therapies for heart disease. It develops medicines to edit the genome of adults that mimic naturally occurring gene variants to lower LDL cholesterol and triglyceride levels. Its products can be used for the treatment of coronary artery and cardiovascular diseases.
|HQ||Cambridge, MA, US||Map|
Market capitalization (29-Sept-2021)
Closing stock price (29-Sept-2021)
Verve Therapeutics has 2.48k Twitter Followers. The number of followers has increased 4.1% month over month and increased 23.6% quarter over quarter
Tweets last 30 days
Avg. likes per Tweet
Tweets with engagement
When was Verve Therapeutics founded?
Verve Therapeutics was founded in 2018.
Who are Verve Therapeutics key executives?
Verve Therapeutics's key executives are Burt Adelman, J. Keith Joung and Anthony Philippakis.
How many employees does Verve Therapeutics have?
Verve Therapeutics has 70 employees.
Who are Verve Therapeutics competitors?
Competitors of Verve Therapeutics include AXON Neuroscience, Mesoblast and OmniSeq.
Where is Verve Therapeutics headquarters?
Verve Therapeutics headquarters is located at NE47, 500 Technology Square #901, Cambridge.
Where are Verve Therapeutics offices?
Verve Therapeutics has an office in Cambridge.
How many offices does Verve Therapeutics have?
Verve Therapeutics has 1 office.
Receive alerts for 300+ data fields across thousands of companies